Canada markets closed

ImmuPharma plc (IMM.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
2.2050-0.0350 (-1.56%)
At close: 03:55PM BST
Currency in GBp

Valuation Measures4

Market Cap (intraday) 9.33M
Enterprise Value 9.12M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)104.74
Price/Book (mrq)5.37
Enterprise Value/Revenue 130.33
Enterprise Value/EBITDA -0.94

Trading Information

Stock Price History

Beta (5Y Monthly) 1.46
52-Week Change 3-27.97%
S&P500 52-Week Change 328.04%
52 Week High 33.8000
52 Week Low 30.8220
50-Day Moving Average 32.1287
200-Day Moving Average 31.8243

Share Statistics

Avg Vol (3 month) 32.95M
Avg Vol (10 day) 32.19M
Shares Outstanding 5416.44M
Implied Shares Outstanding 6416.44M
Float 8253.25M
% Held by Insiders 143.00%
% Held by Institutions 121.11%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,855.94%

Management Effectiveness

Return on Assets (ttm)-53.90%
Return on Equity (ttm)-159.35%

Income Statement

Revenue (ttm)69.96k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -2.57M
Net Income Avi to Common (ttm)-2.99M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)210.58k
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.17
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-1.38M
Levered Free Cash Flow (ttm)-1.48M